HOME >> MEDICINE >> NEWS
American Association of Pharmaceutical Scientists tapped to manage PQRI

ALEXANDRIA, Va., Nov. 16 -- In effort to reduce the regulatory burden on the Food and Drug Administration (FDA) and the pharmaceutical industry, the American Association of Pharmaceutical Scientists (AAPS) announced today the formation of the Product Quality Research Institute (PQRI). The goal of this collaborative effort between the government, industry and academia is to produce science-based policy that ensures quality reviews without unnecessary testing. The Institute's recommendations are expected to speed new drug approvals and reduce the industry's cost for pharmaceutical development. Ultimately, the public will benefit because of lower costs and faster availability of new drugs for life-threatening diseases.

"We are not testing actual drugs," said Larry Augsburger, AAPS President. "We are testing processes and procedures that will be used to help verify pharmaceutical properties and their effectiveness. Recommendations will help fast-track pharmaceuticals, benefiting all Americans, especially those who currently have no disease treatment options available."

How PQRI Works

Under the purview of AAPS, PQRI will consist of a board of directors, a steering committee and technical committees. The five-member board of directors is charged with the administrative management and operations of the Institute. The board has authority over the collection and disbursement of funds and the administrative procedures required to guarantee effective operations.

Following the lead of the technical committee, working groups of scientists will perform research projects aimed at streamlining policy, while still ensuring the highest level of product quality. The technical committee then reviews the findings for scientific validity. Assuming approval, the steering committee votes on whether or not to make a recommendation to the FDA. The FDA can either accept or reject the findings.

"PQRI represents a unique collaboration between F
'"/>

Contact: Marie Bertot
305-573-9955
American Association of Pharmaceutical Scientists
15-Nov-1999


Page: 1 2

Related medicine news :

1. Consumers with disabilities empowered by American Disabilities Act
2. Definition of persistent vegetative state available from American Academy of Neurology
3. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
4. New colorectal cancer screening recommendations for African Americans
5. American Thoracic Society Journal news tips for March 2005 (second issue)
6. Community care tops medical care at preventing heart disease in black Americans
7. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
8. Obesity among African-American stroke survivors increases risk factors for recurrent stroke
9. Awards & fellowships at the International & American Association for Dental Research General Session
10. American Academy of Neurology presents 57th Annual Meeting in Miami Beach
11. News tips from the 2005, 54th Annual Scientific Sessions of the American College of Cardiology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... ... distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in ... and patient safety. Only a few hospitals and facilities have earned this distinction. ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Chester County, a Property owned by an affiliate of Seavest, has won a ... Penn Medicine Southern Chester County ambulatory care center (ACC) was named “Best New ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick Taché ... Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is a ... & Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011. ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... -- Global Interventional Radiology Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology:
Cached News: